164 related articles for article (PubMed ID: 18221116)
1. Inhibitors of mammalian acetyl-CoA carboxylase.
Corbett JW; Harwood JH
Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):162-80. PubMed ID: 18221116
[TBL] [Abstract][Full Text] [Related]
2. Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition.
Harwood HJ
Expert Opin Ther Targets; 2005 Apr; 9(2):267-81. PubMed ID: 15934915
[TBL] [Abstract][Full Text] [Related]
3. Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome.
Harwood HJ
Curr Opin Investig Drugs; 2004 Mar; 5(3):283-9. PubMed ID: 15083594
[TBL] [Abstract][Full Text] [Related]
4. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
[TBL] [Abstract][Full Text] [Related]
5. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.
Corbett JW
Expert Opin Ther Pat; 2009 Jul; 19(7):943-56. PubMed ID: 19552511
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors.
Chen L; Duan Y; Wei H; Ning H; Bi C; Zhao Y; Qin Y; Li Y
Expert Opin Investig Drugs; 2019 Oct; 28(10):917-930. PubMed ID: 31430206
[No Abstract] [Full Text] [Related]
7. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.
Harriman G; Greenwood J; Bhat S; Huang X; Wang R; Paul D; Tong L; Saha AK; Westlin WF; Kapeller R; Harwood HJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1796-805. PubMed ID: 26976583
[TBL] [Abstract][Full Text] [Related]
8. Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2.
Corbett JW; Freeman-Cook KD; Elliott R; Vajdos F; Rajamohan F; Kohls D; Marr E; Zhang H; Tong L; Tu M; Murdande S; Doran SD; Houser JA; Song W; Jones CJ; Coffey SB; Buzon L; Minich ML; Dirico KJ; Tapley S; McPherson RK; Sugarman E; Harwood HJ; Esler W
Bioorg Med Chem Lett; 2010 Apr; 20(7):2383-8. PubMed ID: 20219367
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery.
Tong L
Cell Mol Life Sci; 2005 Aug; 62(16):1784-803. PubMed ID: 15968460
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes.
Cheng D; Chu CH; Chen L; Feder JN; Mintier GA; Wu Y; Cook JW; Harpel MR; Locke GA; An Y; Tamura JK
Protein Expr Purif; 2007 Jan; 51(1):11-21. PubMed ID: 16854592
[TBL] [Abstract][Full Text] [Related]
11. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential.
Luo DX; Tong DJ; Rajput S; Wang C; Liao DF; Cao D; Maser E
Recent Pat Anticancer Drug Discov; 2012 May; 7(2):168-84. PubMed ID: 22339356
[TBL] [Abstract][Full Text] [Related]
12. Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.
Marjanovic J; Chalupska D; Patenode C; Coster A; Arnold E; Ye A; Anesi G; Lu Y; Okun I; Tkachenko S; Haselkorn R; Gornicki P
Proc Natl Acad Sci U S A; 2010 May; 107(20):9093-8. PubMed ID: 20439761
[TBL] [Abstract][Full Text] [Related]
13. Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.
Bengtsson C; Blaho S; Saitton DB; Brickmann K; Broddefalk J; Davidsson O; Drmota T; Folmer R; Hallberg K; Hallén S; Hovland R; Isin E; Johannesson P; Kull B; Larsson LO; Löfgren L; Nilsson KE; Noeske T; Oakes N; Plowright AT; Schnecke V; Ståhlberg P; Sörme P; Wan H; Wellner E; Oster L
Bioorg Med Chem; 2011 May; 19(10):3039-53. PubMed ID: 21515056
[TBL] [Abstract][Full Text] [Related]
14. Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs.
Wu X; Huang T
Future Med Chem; 2020 Mar; 12(6):533-561. PubMed ID: 32048880
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes.
Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H
Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of acetyl-CoA carboxylase isoforms by pyridoxal phosphate.
Lee WM; Elliott JE; Brownsey RW
J Biol Chem; 2005 Dec; 280(51):41835-43. PubMed ID: 16249179
[TBL] [Abstract][Full Text] [Related]
17. Structure, function and selective inhibition of bacterial acetyl-coa carboxylase.
Polyak SW; Abell AD; Wilce MC; Zhang L; Booker GW
Appl Microbiol Biotechnol; 2012 Feb; 93(3):983-92. PubMed ID: 22183085
[TBL] [Abstract][Full Text] [Related]
18. Cyclohexanedione herbicides are inhibitors of rat heart acetyl-CoA carboxylase.
Seng TW; Skillman TR; Yang N; Hammond C
Bioorg Med Chem Lett; 2003 Oct; 13(19):3237-42. PubMed ID: 12951100
[TBL] [Abstract][Full Text] [Related]
19. Phenoxy thiazole derivatives as potent and selective acetyl-CoA carboxylase 2 inhibitors: Modulation of isozyme selectivity by incorporation of phenyl ring substituents.
Clark RF; Zhang T; Wang X; Wang R; Zhang X; Camp HS; Beutel BA; Sham HL; Gu YG
Bioorg Med Chem Lett; 2007 Apr; 17(7):1961-5. PubMed ID: 17267221
[TBL] [Abstract][Full Text] [Related]
20. Discovery of acetyl-coenzyme A carboxylase 2 inhibitors: comparison of a fluorescence intensity-based phosphate assay and a fluorescence polarization-based ADP Assay for high-throughput screening.
Liu Y; Zalameda L; Kim KW; Wang M; McCarter JD
Assay Drug Dev Technol; 2007 Apr; 5(2):225-35. PubMed ID: 17477831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
